NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma

Leukemia. 2017 Feb;31(2):498-501. doi: 10.1038/leu.2016.292. Epub 2016 Oct 24.

Authors

E Pomari^{1

2}, G Basso¹, S Bresolin^{1

2}, M Pillon¹, E Carraro¹, E S d'Amore³, G Viola^{1

2}, C Frasson², K Basso⁴, P Bonvini², L Mussolin^{1

2}

Affiliations

¹ Department of Women's and Children's Health, Clinic of Pediatric Hemato-Oncology, University of Padova, Padova, Italy.
² Istituto di Ricerca Pediatrica, Fondazione Città della Speranza, Padova, Italy.
³ Institute of Pathology, San Bortolo Hospital, Vicenza, Italy.
⁴ Institute for Cancer Genetics, Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.

PMID: 27773932
DOI: 10.1038/leu.2016.292

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Child
Humans
Lymphoma, Large-Cell, Anaplastic / classification
Lymphoma, Large-Cell, Anaplastic / metabolism*
Protein-Tyrosine Kinases / metabolism*

Substances

p80(NPM-ALK) protein
Protein-Tyrosine Kinases